Page last updated: 2024-12-11
colneleic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
colneleic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
colneleic acid : A long-chain, divinyl ether fatty acid composed of 8-nonenoic acid having the E- hydrogen at position 9 substituted by a (1E,3Z)-nona-1,3,-dien-1-yloxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6441681 |
| CHEBI ID | 60956 |
| SCHEMBL ID | 2369985 |
| MeSH ID | M0043794 |
Synonyms (20)
| Synonym |
|---|
| 9-oxa-8t10t12c-18:3 |
| CHEBI:60956 |
| (8e,1'e,3'z)-9-(1',3'-nonadienyloxy)-8-nonenoic acid |
| colneleinsaeure |
| 52761-34-9 |
| 9-oxa-8t10t12c-c18:3 |
| LMFA10000001 |
| colneleic acid |
| 9-[1'e,3'z-dien-1'-yloxy]-non-8e-enoic acid |
| (8e)-9-[(1e,3z)-nona-1,3-dien-1-yloxy]non-8-enoic acid |
| C19827 |
| 9-(nona-1',3'-dienoxy)non-8-enoic acid |
| 8-nonenoic acid, 9-(1,3-nonadienyloxy)-, (e,e,z)- |
| SCHEMBL2369985 |
| (2'e,4'z,8e)-colneleic acid |
| 9-(1,3-nonadienyloxy)-(e,e,z)-8-nonenoic acid |
| 9-[1-l (e),3-l (z)-nonadienyloxy]-8(e)-nonenoic acid |
| Q27130252 |
| (8e)-9-[(1e,3z)-1,3-nonadien-1-yloxy]-8-nonenoic acid |
| DTXSID501214758 |
Research Excerpts
Overview
Colneleic acid is an unsaturated ether fatty acid. It is derived from linoleic acid via a lipoxygenase-mediated enzyme pathway.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Colneleic acid is an unsaturated ether fatty acid derived from linoleic acid via a lipoxygenase-mediated enzyme pathway. " | ( The enzymic and non-enzymic degradation of colneleic acid, an unsaturated fatty acid ether intermediate in the lipoxygenase pathway of linoleic acid oxidation in potato (Solanum tuberosum) tubers. Galliard, T; Mathew, JA; Wardale, DA, 1974) | 1.96 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (3)
| Class | Description |
|---|---|
| divinyl ether fatty acid | An oxa fatty acid in which the defining oxa group forms part of a divinyl ether. |
| long-chain fatty acid | A fatty acid with a chain length ranging from C13 to C22. |
| straight-chain fatty acid | Any fatty acid whose skeletal carbon atoms form an unbranched open chain. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||